Date published: 2026-2-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF774 Inhibitors

ZNF774 inhibitors represent a class of compounds specifically designed to reduce or abrogate the activity of the zinc finger protein ZNF774. As a member of the zinc finger protein family, ZNF774 is involved in DNA binding and gene regulation, typically modulating the expression of various genes by binding to their promoters or enhancers. The inhibitors of ZNF774 would, therefore, interfere with these processes, leading to a change in gene expression profiles within the cell. Given the nature of ZNF774 as a transcription factor, its inhibitors would likely function by disrupting the protein-DNA interaction or by hindering the protein's ability to undergo necessary conformational changes essential for binding. The exact mechanisms of these inhibitors depend on the structure of ZNF774 itself, as well as the particular domains within the protein that are crucial for its interaction with DNA. Small molecules might bind directly to the DNA-binding domain of ZNF774, preventing its interaction with DNA, while others might alter the folding or stability of ZNF774, leading to a reduction in its functional form within the nucleus.

The development of ZNF774 inhibitors is a complex task, requiring a deep understanding of the protein's structure and function. These compounds may be designed to bind to the zinc finger motifs themselves, which are the defining structural elements of the protein that coordinate zinc ions and stabilize the protein's interaction with DNA. Alternatively, inhibitors might target allosteric sites, which are regions of the protein distant from the active site but still capable of influencing the protein's activity when bound by a ligand. By binding to these allosteric sites, the inhibitors could induce conformational changes that propagate through the protein, ultimately affecting the DNA-binding domain. In addition, ZNF774 inhibitors might also work by mimicking or competing with the natural DNA sequences that ZNF774 targets, thereby preventing the protein from engaging its physiological binding sites. These inhibitors, through their precision in targeting specific protein functions, could offer insights into the regulatory roles played by ZNF774 in gene expression and signal transduction pathways. The exploration of these compounds contributes to a broader understanding of the biological significance of zinc finger proteins and their potential as targets in various biochemical pathways.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A kinase inhibitor that blocks ATP binding sites on kinases which may downregulate ZNF774 by inhibiting phosphorylation processes that could be crucial for its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can decrease AKT phosphorylation, potentially reducing the transcriptional activity of ZNF774 if it is AKT-dependent.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A MEK inhibitor which impedes the MAPK/ERK pathway, potentially altering the expression levels or function of ZNF774 if it is regulated by this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor which can lead to a decrease in protein synthesis and potentially inhibit ZNF774 expression if it is mTOR-dependent.

Chetomin

1403-36-7sc-202535
sc-202535A
1 mg
5 mg
$186.00
$674.00
10
(1)

Disrupts the interaction between hypoxia-inducible factors (HIF) and p300, potentially downregulating ZNF774 if it is under HIF regulation.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Inhibits Hsp90 which may impact the stability and function of client proteins, potentially leading to decreased levels or activity of ZNF774.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Inhibits the Hedgehog signaling pathway, which could reduce the expression or activity of ZNF774 if it is part of this pathway.

WZ4003

1214265-58-3sc-473979
5 mg
$300.00
(0)

A NUAK1 inhibitor, may lead to a decrease in MYPT1 phosphorylation, potentially affecting ZNF774 function if it interacts with this pathway.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can lead to increased cellular stress and potentially downregulate ZNF774 through the unfolded protein response.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

A CDK4/6 inhibitor that may result in cell cycle arrest and consequent downregulation of ZNF774 if its expression is cell cycle-dependent.